Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

CapsoVision, Inc. (CV) vs TriSalus Life Sciences, Inc. (TLSI)

CapsoVision, Inc. and TriSalus Life Sciences, Inc. are both Medical Devices companies. CapsoVision, Inc. and TriSalus Life Sciences, Inc. are of similar size ($328.3M and $303.6M). TriSalus Life Sciences, Inc. has negative trailing earnings, so its P/E is not meaningful; CapsoVision, Inc. trades at 2.1×. TriSalus Life Sciences, Inc. grew revenue faster over the last twelve months: 25.3% against 16.7%. TriSalus Life Sciences, Inc. has the higher net margin (−127.0% vs −214.7%) and the higher return on invested capital (0.00% vs −460.9%). Across the 17 metrics below, TriSalus Life Sciences, Inc. leads on 12 and CapsoVision, Inc. on 5.

Valuation

Metric CV TLSI Medical Devices median
P/E 2.09 n/m 22.18
P/S 23.91 5.61 2.70
P/B 25.22 38.63 2.46
Price to free cash flow n/m n/m 22.53
EV/EBITDA n/m n/m 11.78
EV/Sales 23.25 5.33 2.38
Earnings yield 47.81% (29.95%) (8.22%)
Free cash flow yield (8.40%) (9.48%) (7.80%)

Profitability

Metric CV TLSI Medical Devices median
Gross margin 50.88% 85.79% 56.01%
Operating margin (217.09%) (67.68%) (15.03%)
Net margin (214.74%) (127.00%) (20.40%)
Free cash flow margin (200.77%) (51.56%) (7.24%)
Return on equity 47.42% 889.44% (15.32%)
Return on assets (212.19%) (110.34%) (19.72%)
Return on invested capital (460.93%) 0.00% (10.33%)

Growth

Metric CV TLSI Medical Devices median
Revenue growth (TTM) 16.66% 25.25% 8.80%
EPS growth (last fiscal year) 89.54% (40.46%) —
Revenue growth, 5-year CAGR — — 15.23%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric CV TLSI Medical Devices median
Debt to equity 0.00 5.05 0.07
Current ratio 3.35 5.35 2.50
Net debt to EBITDA 0.41 (0.50) 0.49

Dividend

Metric CV TLSI Medical Devices median
Dividend yield — — 0.94%
Payout ratio — 0.00 0.00

Size

Metric CV TLSI Medical Devices median
Market cap 328.31m 303.56m 172.91m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack